BRIEF published on 04/06/2026 at 15:25, 5 months 10 days ago The Vanguard Group, Inc.: Disclosure on JTC plc Holdings Form 8.3 Takeover Code Securities Disclosure Vanguard Group JTC Plc
PRESS RELEASE published on 04/06/2026 at 15:24, 5 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.55% interest in Schroders plc with 41,000,051 relevant securities as of 02 April 2026 The Vanguard Group, Inc. Relevant Securities Takeover Code Schroders Plc Interest Disclosure
PRESS RELEASE published on 04/06/2026 at 15:21, 5 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% interest in Beazley plc with 30,147,894 shares owned. Purchased additional 16,397 shares at 12.72-12.73 GBP Disclosure The Vanguard Group Share Purchase Interests Beazley Plc
PRESS RELEASE published on 04/06/2026 at 15:20, 5 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.09% stake in JTC plc. Details of ownership and dealings per regulatory requirement Relevant Securities Financial Dealings The Vanguard Group Ownership Disclosure JTC Plc
BRIEF published on 04/02/2026 at 15:37, 5 months 14 days ago Vanguard Group Discloses Significant Position in Spire Healthcare Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
BRIEF published on 04/02/2026 at 15:35, 5 months 14 days ago The Vanguard Group, Inc. Discloses Position in Schroders plc Form 8.3 Takeover Code Securities Disclosure Vanguard Schroders
BRIEF published on 04/02/2026 at 15:34, 5 months 14 days ago The Vanguard Group Discloses Position in Picton Property Income Securities Disclosure The Vanguard Group Takeover Code Picton Property Income
BRIEF published on 04/02/2026 at 15:33, 5 months 14 days ago The Vanguard Group Discloses Position in NCC Group Form 8.3 Securities Disclosure Vanguard Group Shareholding NCC Group
PRESS RELEASE published on 04/02/2026 at 15:32, 5 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses holding 3.61% interest in Spire Healthcare Group plc as of 01 April 2026. Transactions include purchase and sale of 1p ordinary shares Transactions The Vanguard Group, Inc. Disclosure 1p Ordinary Shares Spire Healthcare Group Plc
BRIEF published on 04/02/2026 at 15:31, 5 months 14 days ago The Vanguard Group Discloses Interests in Property Consortium Form 8.3 Securities Disclosure Vanguard Group LondonMetric Property Schroder Real Estate
Published on 09/16/2026 at 23:45, 6 hours 15 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 8 hours 30 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 13 hours 5 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 14:00, 16 hours ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 04:25, 1 hour 35 minutes ago Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 6 hours 15 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 7 hours 26 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 8 hours 45 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 9 hours 33 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 17:45, 12 hours 15 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 23 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 12 hours ago Report on the Combined General Meeting of the 10th of September 2026
